NASDAQ, CBPO - China Biologic Produ
We are a biopharmaceutical company and through our indirect majority-owned
Chinese subsidiary, Shandong Taibang, we are principally engaged in the
research, development, production and manufacturing of plasma-based
pharmaceutical products in China. Shandong Taibang operates from our
manufacturing facility located in Taian City, Shandong Province. The
plasma-based biopharmaceutical manufacturing industry in China is highly
restricted by both the provincial and central governments. Accordingly, the
manufacturing process of our products is strictly monitored from the initial
collection of plasma from human donors to finished products. Our principal
products include our approved human albumin and immunoglobulin products.
We are approved to sell human albumin 20%/10ml, 20%/25ml and 20%/50ml. Human
albumin is our top-selling product. Sales of these human albumin products
represented approximately 63.6% and 75. ...
Read SEC Filing on NASDAQ.com »